Strides Pharma Science Ltd Share Price (STAR)
as on
| Source : NSE
Strides Pharma Science Ltd Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
₹863.15₹875.45
0.27%
Downside
1.15%
Upside
52 Week's Low
52 Week's High
₹513.05₹1,67540.72%
Downside
93.53%
Upside
| Market Stats | |
| Previous Close | ₹875.35 |
| Open | ₹873.00 |
| Volume | 92.52K |
| Upper Circuit | ₹1,050.40 |
| Lower Circuit | ₹700.30 |
| Day's Low | ₹863.15 |
| Day's High | ₹875.45 |
| 52 Week Low | ₹513.05 |
| 52 Week High | ₹1,675 |
| Returns % | |
| 1 Month Return | -0.28 % |
| 3 Month Return | + 19.85 % |
| 1 Year Return | -33.14 % |
| 3 Year Return | + 156.74 % |
| 5 Year Return | + 45.72 % |
Strides Pharma Science Ltd Stock Fundamentals & Key Indicators
Check Strides Pharma Science Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹8,068.34 Cr
Return on Equity (ROE)
85.9
PE Ratio (TTM)
26.76
Return on capital employed (ROCE)
4.62
Industry PE ratio
43.37
Beta (LTM)
1.13
P/B Ratio
1.93
Dividend Yield
0.6
PEG Ratio
-0.22
Quarterly Earnings Growth YOY
-96.85
EPS (TTM)
390.34
Sector
Pharmaceuticals
Book Value
276.88
Technical Analysis
Bullish
View Technical Analysis
Strides Pharma Science Ltd Stock's Interest Amongst Investors
Strides Pharma Science Ltd Stock Valuation
Track how Strides Pharma Science Ltd P/E has moved over time to understand its valuation trends.
Strides Pharma Science Ltd in the last 5 years
Lowest (-409.06x)
July 5, 2021
Today (26.76x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (1089.10x)
January 7, 2021
Today’s Price to Earnings Ratio: 26.76x
Strides Pharma Science Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Strides Pharma Science Ltd.
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Strides Pharma Science Ltd. Average target price of ₹1078.5
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Share Price Target
Get share price movements and forecasts by analysts on Strides Pharma Science Ltd.
Strides Pharma Science Ltd price forecast by 2 analysts
Upside of23.21%
High
₹1220
Target
₹1078.50
Low
₹937
Strides Pharma Science Ltd target price ₹1078.5, a slight upside of 23.21% compared to current price of ₹865.5. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Strides Pharma Science Ltd revenue growth forecast
Expected growth rate Q1, FY2027:26.52%
Forecast
Actual
Including amortisation and stock based compensations
Strides Pharma Science Ltd EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Strides Pharma Science Ltd Financial Results
Get the annual and quarterly financial summary of Strides Pharma Science Ltd, including revenue, profit, loss and more.
Strides Pharma Science Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Strides Pharma Science Ltd.
Strides Pharma Science Ltd Earnings Results
Strides Pharma Science Ltd’s net profit fell -97.03% since last year same period to ₹99.61Cr in the Q1 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 21.19% jump in its net profits since last 3-months.
Read More about Earnings ResultsStrides Pharma Science Ltd Dividends May,2025
In the quarter ending March 2025, Strides Pharma Science Ltd has declared dividend of ₹4.00 per share on 22 May 2025 - translating a dividend yield of 0.74%.
Read More about Dividends
Indices Featuring Strides Pharma Science Ltd Stock
Check stock indices that include Strides Pharma Science Ltd.
Strides Pharma Science Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Strides Pharma Science Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 28.3% | 0.00 | |
| Foreign Institutions | 28.02% | ||
| Mutual Funds | 8.82% | ||
| Retail Investors | 30.37% | 2.43 | |
| Others | 4.49% |
Strides Pharma Science Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Strides Pharma Science Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 8,068.34 | 9.14% | 0.72 | 3,597 | 4,565 | |
| NA | 144.70 | 17.83% | 0.84 | 7 | 339 | |
| NA | 509.12 | 22.09% | 0.00 | NA | NA | |
| NA | 732.08 | 31.15% | 0.51 | 421 | 1,280 | |
| NA | 6.03 | -7.89% | 0.00 | -6 | NA |
Strides Pharma Science Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Strides Pharma Science Ltd.
Strides Pharma Reports Strong Q1 Earnings Growth - 29 Jul, 2025
Strides Pharma Science Ltd announced robust Q1 results with an 81% increase in PAT to ₹114 crore and a 6.2% rise in revenue to ₹1,119.7 crore. The company attributed its success to cost management and plans to enhance R&D efforts for sustainable growth. Shares surged over 3%, reaching a 52-week high.Strides Pharma Schedules Board Meeting for Financial Results - 24 Jul, 2025
Strides Pharma Science has announced a Board meeting on July 29, 2025, to approve un-audited financial results for Q2 2025. The trading window is closed from July 1, 2025.Strides Pharma Declares Final Dividend for FY25 - 21 Jul, 2025
Strides Pharma Science has announced a final dividend of ₹4 per share for FY25, with the record date set for July 22, 2025.
Insights on Strides Pharma Science Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 82.19 Cr → 99.61 Cr (in ₹), with an average increase of 17.5% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, STAR has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 29.65% to 30.37% in Jun 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 28.30% of holdings in Jun 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 55.9%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 28.32% to 28.02% in Jun 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, STAR stock has moved down by -2.9%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.20K Cr → 1.12K Cr (in ₹), with an average decrease of 6.4% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 8.89% to 8.82% in Jun 2025 quarter
About Strides Pharma Science Ltd
Revenue: ₹1,119.74Cr as on June 2025 (Q1 FY26)
Net Profit: ₹105.59Cr as on June 2025 (Q1 FY26)
Listing date: 02 Feb, 2000
Chairperson Name: Arun Kumar
| Organisation | Strides Pharma Science Ltd |
| Headquarters | Bangaluru |
| Industry | Pharmaceuticals |
| CEO | Arun Kumar |
| E-voting on shares | Click here to vote |
Mutual Funds that own Strides Pharma Science Ltd Stock
Check out the Mutual Funds with significant holdings in Strides Pharma Science Ltd.
FAQs
What is Strides Pharma Science Ltd share price today?
Strides Pharma Science Ltd share price today stands at ₹865.5, Open: ₹873, Previous Close: ₹875.35, High: ₹875.45, Low: ₹863.15, 52 Week High: ₹1675, 52 Week Low: ₹513.05 as on .
How to buy Strides Pharma Science Ltd shares ?
To buy Strides Pharma Science Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for STAR or Strides Pharma Science Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Strides Pharma Science Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Strides Pharma Science Ltd?
Today's traded volume of Strides Pharma Science Ltd is 92.52K. Which means that 92.52K shares of Strides Pharma Science Ltd were bought and sold on the stock market during today's trading session.
What is Strides Pharma Science Ltd's market cap today?
Today's market capitalisation of Strides Pharma Science Ltd is ₹8,068.34 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Strides Pharma Science Ltd?
Strides Pharma Science Ltd’s 52 week high is ₹1675 and 52 week low is ₹513.05. The current share price of Strides Pharma Science Ltd is ₹865.5, which is -48.33% down from its 52 week high and 68.70% up from its 52 week low.